Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

Hoisnard, L., Lebrun-Vignes, B., Maury, S. et al. Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database. Sci Rep 12, 7140 (2022).

Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome

Ingrosso MR, Ianiro G, Nee J, Lembo AJ, Moayyedi P, Black CJ, Ford AC. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Aliment Pharmacol Ther. 2022 Sep;56(6):932-941. doi: 10.1111/apt.17179.
PMID: 35942669

Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection

Dihub Natarajan, A., Zlitni, S., Brooks, E. F., Vance, S. E., Dahlen, A., Hedlin, H., Park, R. M., Han, A., Schmidtke, D. T., Verma, R., Jacobson, K. B., Parsonnet, J., Bonilla, H. F., Singh, U., Pinsky, B. A., Andrews, J. R., Jagannathan, P., & Bhatt, A. S. (2022). Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med, 3(6), 371-387.e9

Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?

Monteleone G, Ardizzone S
J Crohns Colitis. 2020 Sep 16;14(9):1334-1336. doi: 10.1093/ecco-jcc/jjaa061
PMID: 32215548

Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience

Fiorino G, Allocca M, Furfaro F, Gilardi D, Zilli A, Radice S, Spinelli A, Danese S
J Crohns Colitis. 2020 Sep 16;14(9):1330-1333. doi: 10.1093/ecco-jcc/jjaa058
PMID: 32211765

Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases

Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, Zhou Y, Sanchez C, Kappelman MD, Uhlig HH, Pujol-Muncunill G, Ledder O, Lionetti P, Dias JA, Ruemmele FM, Russell RK; Paediatric IBD Porto group of ESPGHAN.
J Pediatr Gastroenterol Nutr. 2020 Jun;70(6):727-733. doi: 10.1097/MPG.0000000000002729.
PMID: 32443020

COVID-19 and inflammatory bowel disease: questions arising from patient care

Marín-Jiménez I, Zabana Y, Rodríguez-Lago I, Marín L, Barreiro-de Acosta M, Esteve M; en representación de GETEII y GETECCU.
Gastroenterol Hepatol. 2020 Aug-Sep;43(7):408-413. doi: 10.1016/j.gastrohep.2020.05.003. Epub 2020 May 15
PMID: 32419715

Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak

D'Amico F, Danese S, Peyrin-Biroulet L; ECCO COVID taskforce
Gastroenterology. 2020 Jul;159(1):14-19.e3. doi: 10.1053/j.gastro.2020.04.059. Epub 2020 Apr 30
PMID: 32360567

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period

Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese S, Kochhar GS, Ghosh S, Shen B
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):598-606. doi: 10.1016/S2468-1253(20)30119-9. Epub 2020 Apr 16.
PMID: 32305075

Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases

Oka A, Sartor RB.
Dig Dis Sci. 2020 Mar;65(3):757-788. doi: 10.1007/s10620-020-06090-z.
PMID: 32006212

Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases

Kienzl M, Storr M, Schicho R.
Clin Transl Gastroenterol. 2020 Jan;11(1):e00120. doi: 10.14309/ctg.0000000000000120.
PMID: 31899693

Stigmatisation and resilience in inflammatory bowel disease

Lenti MV, Cococcia S, Ghorayeb J, Di Sabatino A, Selinger CP.
Intern Emerg Med. 2020 Mar;15(2):211-223. doi: 10.1007/s11739-019-02268-0. Epub 2019 Dec 31.
PMID: 31893346

Fatigue in Inflammatory Bowel Diseases: Etiologies and Management

Nocerino A, Nguyen A, Agrawal M, Mone A, Lakhani K, Swaminath A.
Adv Ther. 2020 Jan;37(1):97-112. doi: 10.1007/s12325-019-01151-w. Epub 2019 Nov 23
PMID: 31760611

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)

El-Salhy M, Hausken T, Hatlebakk JG
Nutrients. 2019 Jun 24;11(6):1415. doi: 10.3390/nu11061415.
PMID: 31238507

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S; AGA Institute Clinical Guidelines Committee.
Gastroenterology. 2020 Apr;158(5):1450-1461. doi: 10.1053/j.gastro.2020.01.006. Epub 2020 Jan 13
PMID: 31945371

Management of ulcerative colitis: summary of updated NICE guidance

Abdulrazeg O, Li B, Epstein J; Guideline Committee.
BMJ. 2019 Oct 28;367:l5897. doi: 10.1136/bmj.l5897
PMID: 31658951

Is Endoscopic Remission in Ulcerative Colitis Still Good Enough?

Bhattacharya S, Cross RK
Inflamm Bowel Dis. 2019 Oct 18;25(11):1729-1730. doi: 10.1093/ibd/izz177
PMID: 31412124

Fecal Microbiota Transplantation in Ulcerative Colitis

Blanchaert C, Strubbe B, Peeters H.
Acta Gastroenterol Belg. 2019 Oct-Dec;82(4):519-528
PMID: 31950808

Recent Advances and Emerging Therapies in the Non-Surgical Management of Ulcerative Colitis

Wehkamp J, Stange EF.
F1000Res. 2018 Aug 7;7:F1000 Faculty Rev-1207. doi: 10.12688/f1000research.15159.1. eCollection 2018
PMID: 30135722

Inflammatory Bowel Disease Presentation and Diagnosis

Flynn S, Eisenstein S
Surg Clin North Am. 2019 Dec;99(6):1051-1062. doi: 10.1016/j.suc.2019.08.001. Epub 2019 Sep 11.
PMID: 31676047

Recent Advances and Emerging Therapies in the Non-Surgical Management of Ulcerative Colitis

Wehkamp J, Stange EF
F1000Res. 2018 Aug 7;7:F1000 Faculty Rev-1207. doi: 10.12688/f1000research.15159.1. eCollection 2018
PMID: 30135722

The so-called "biologicals" (monoclonal antibodies to various inflammatory targets like tumor necrosis factor or integrins)....

Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis

Ding X, Li Q, Li P, Zhang T, Cui B, Ji G, Lu X, Zhang F
Drug Saf. 2019 Jul;42(7):869-880. doi: 10.1007/s40264-019-00809-2
PMID: 30972640

Diet in the Pathogenesis and Management of Ulcerative Colitis; A Review of Randomized Controlled Dietary Interventions

Keshteli AH, Madsen KL, Dieleman LA.
Nutrients. 2019 Jun 30;11(7):1498. doi: 10.3390/nu11071498
PMID: 31262022

Relationship Between Intestinal Microbiota and Ulcerative Colitis: Mechanisms and Clinical Application of Probiotics and Fecal Microbiota Transplantation

Shen ZH, Zhu CX, Quan YS, Yang ZY, Wu S, Luo WW, Tan B, Wang XY
World J Gastroenterol. 2018 Jan 7;24(1):5-14. doi: 10.3748/wjg.v24.i1.5
PMID: 29358877